Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma
Clinical trial NCT03886311 · RECRUITING
Trial details
- NCT number
- NCT03886311
- Sponsor
- Sarcoma Oncology Research Center, LLC
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-15
- Primary completion
- 2030-12-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.